Search Results - "BONGARZONE, I"

Refine Results
  1. 1

    Sulfatide imaging identifies tumor cells in colorectal cancer peritoneal metastases by Sarcinelli, G M, Varinelli, L, Ghislanzoni, S, Padelli, F, Lorenzini, D, Vingiani, A, Milione, M, Guaglio, M, Kusamura, S, Deraco, M, Pruneri, G, Gariboldi, M, Baratti, D, Bongarzone, I

    Published in Cancer & metabolism (28-06-2024)
    “…Even with systemic chemotherapy, cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC), peritoneal metastases (PM) remain a common…”
    Get full text
    Journal Article
  2. 2

    Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer by Orlandi, R., De Bortoli, M., Ciniselli, C.M., Vaghi, E., Caccia, D., Garrisi, V., Pizzamiglio, S., Veneroni, S., Bonini, C., Agresti, R., Daidone, M.G., Morelli, D., Camaschella, C., Verderio, P., Bongarzone, I.

    Published in Annals of oncology (01-02-2014)
    “…Currently used CA15–3 and CEA have found their clinical application particularly in the follow-up of patients with advanced disease. Novel biomarkers are…”
    Get full text
    Journal Article
  3. 3

    Proteomic profile in familial breast cancer patients by Garrisi, V.M., Tommasi, S., Facchiano, A., Bongarzone, I., De Bortoli, M., Cremona, M., Cafagna, V., Abbate, I., Tufaro, A., Quaranta, M., Paradiso, A.

    Published in Clinical biochemistry (01-02-2013)
    “…Breast cancer is the most common form of cancer affecting women, and the strongest risk factor remains family history. Although screening in asymptomatic women…”
    Get full text
    Journal Article
  4. 4

    Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib by Garrisi, V.M., Bongarzone, I., Mangia, A., Cremona, M., De Bortoli, M., Vaghi, E., Galetta, D., Pastorino, U., Quaranta, M., Abbate, I., Paradiso, A.

    Published in Clinical biochemistry (01-07-2011)
    “…The purpose of this study was to evaluate the efficacy of a protein-based pattern in serum previously determined by MALDI-TOF-MS (Matrix Assisted Laser…”
    Get full text
    Journal Article
  5. 5

    SH2B1β adaptor is a key enhancer of RET tyrosine kinase signaling by DONATELLO, S, FIORINO, A, DEGL'INNOCENTI, D, ALBERTI, L, MIRANDA, C, GORLA, L, BONGARZONE, I, RIZZETTI, M. G, PIEROTTI, M. A, BORRELLO, M. G

    Published in Oncogene (04-10-2007)
    “…The RET gene encodes two main isoforms of a receptor tyrosine kinase (RTK) implicated in various human diseases. Activating germ-line point mutations are…”
    Get full text
    Journal Article
  6. 6

    Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: Identification of new signaling elements by Gorla, L., Mondellini, P., Cuccuru, G., Miccichè, F., Cassinelli, G., Cremona, M., Pierotti, M.A., Lanzi, C., Bongarzone, I.

    Published in Molecular carcinogenesis (01-03-2009)
    “…Proteomics may help to elucidate differential signaling networks underlying the effects of compounds and to identify new therapeutic targets. Using a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features by BONGARZONE, I, VIGNERI, P, MARIANI, L, COLLINI, P, PILOTTI, S, PIEROTTI, M. A

    Published in Clinical cancer research (01-01-1998)
    “…The papillary carcinoma family (PCF) of thyroid tumors includes a wide variety of neoplastic entities regarded as well-differentiated, poorly differentiated,…”
    Get full text
    Journal Article
  9. 9

    Thyroid iatrogenic sequelae after the treatment of pediatric cancer by Massimino, M, Gandola, L, Seregni, E, Bongarzone, I, Morosi, C, Collini, P

    “…Incidental/therapeutic thyroid irradiation causes hypothyroidism and nodular disease. As increasing numbers of children, adolescents and young adults are being…”
    Get full text
    Journal Article
  10. 10

    Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma by BONGARZONE, I, FUGAZZOLA, L, VIGNERI, P, MARIANI, L, MONDELLINI, P, PACINI, F, BASOLO, F, PINCHERA, A, PILOTTI, S, PIEROTTI, M. A

    “…Oncogenic rearrangements of RET and NTRK1 proto-oncogenes are frequently detected in papillary thyroid carcinomas. Several studies have shown an association…”
    Get full text
    Journal Article
  11. 11

    RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism by Gorla, L., Cantù, M., Miccichè, F., Patelli, C., Mondellini, P., Pierotti, M.A., Bongarzone, I.

    Published in Cellular signalling (01-12-2006)
    “…We report the identification of proteins induced in response to RET/PTC2, an oncogene implicated in thyroid cancers. Anti-phosphotyrosine antibody affinity…”
    Get full text
    Journal Article
  12. 12

    Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas by BONGARZONE, I, BUTTI, M. G, CORONELLI, S, BORRELLO, M. G, SANTORO, M, MONDELLINI, P, PILOTTI, S, FUSCO, A, DELLA PORTA, G, PIEROTTI, M. A

    Published in Cancer research (Chicago, Ill.) (01-06-1994)
    “…Tumor specific rearrangements of ret gene are frequently detected in papillary thyroid carcinomas. These rearrangements result in the formation of chimeric…”
    Get full text
    Journal Article
  13. 13

    Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas by Di Renzo, M F, Olivero, M, Ferro, S, Prat, M, Bongarzone, I, Pilotti, S, Belfiore, A, Costantino, A, Vigneri, R, Pierotti, M A

    Published in Oncogene (01-12-1992)
    “…The receptor for Hepatocyte Growth Factor is a transmembrane tyrosine kinase encoded by the c-MET oncogene. We have previously shown that the Met protein is…”
    Get more information
    Journal Article
  14. 14

    TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas by Greco, A, Pierotti, M A, Bongarzone, I, Pagliardini, S, Lanzi, C, Della Porta, G

    Published in Oncogene (01-02-1992)
    “…We have recently reported the frequent activation of the TRK oncogene in human papillary thyroid carcinoma. In this paper we describe the isolation and…”
    Get more information
    Journal Article
  15. 15

    Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype by SANTORO, M, CARLOMAGNO, F, PEIX, J. L, PAULIN, C, FABIEN, N, VECCHIO, G, JENKINS, R. B, FUSCO, A, HAY, I. D, HERRMANN, M. A, GRIECO, M, MELILLO, R, PIEROTTI, M. A, BONGARZONE, I, DELLA PORTA, G, BERGER, N

    Published in The Journal of clinical investigation (01-05-1992)
    “…We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. This oncogene, papillary thyroid carcinoma (PTC), is a novel…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma by Bongarzone, I, Pierotti, M A, Monzini, N, Mondellini, P, Manenti, G, Donghi, R, Pilotti, S, Grieco, M, Santoro, M, Fusco, A

    Published in Oncogene (01-12-1989)
    “…We had previously detected a transforming oncogene, designated PTC, in 25% of 20 papillary thyroid carcinomas. In order to characterize further the…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas by Pierotti, M A, Vigneri, P, Bongarzone, I

    Published in Recent results in cancer research (1998)
    “…A combined cytogenetic and molecular analysis of thyroid tumours has indicated that these neoplasms might represent a significant model for analysing human…”
    Get more information
    Journal Article